Deutsche Bank’s Aprea Therapeutics APRE Stock Holding History

Deutsche Bank’s Portfolio APRE Stock Details APRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,719	Closed	-$461K	–	4392
2021 Q2	$461K	Buy	4,719 +89	+2%	+$8.22K	﹤0.01%	3277
2021 Q1	$472K	Buy	4,630 +4,349	+1,548%	+$507K	﹤0.01%	3140
2020 Q4	$27K	Buy	281 +87	+45%	+$41.4K	﹤0.01%	4215
2020 Q3	$93K	Buy	194 +18	+10%	+$10.1K	﹤0.01%	3584
2020 Q2	$136K	Buy	176 +64	+57%	+$42K	﹤0.01%	3304
2020 Q1	$78K	Sell	112 -7	-6%	-$5.14K	﹤0.01%	3348
2019 Q4	$108K	Buy	+119	New	+$65.5K	﹤0.01%	3548

Other funds holding APRE

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's APRE Position: Q3 2021 in Review

Deutsche Bank sold out of Aprea Therapeutics (APRE) in Q3 2021, closing a stake of 4,719 shares — an estimated $461K sold.

Deutsche Bank first reported a position in APRE in Q4 2019 and held it in 7 quarters. The position peaked at $472K in Q1 2021. 39 funds tracked by Wall St. Rank hold APRE as of Q3 2021.

Deutsche Bank reported no remaining Aprea Therapeutics position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 4,719 Aprea Therapeutics shares in Q3 2021, an estimated $461K.
Deutsche Bank first reported a position in Aprea Therapeutics in Q4 2019 and held it in 7 quarters.
Deutsche Bank's Aprea Therapeutics position peaked at $472K in Q1 2021.
39 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.